The increase in CETC during tamoxifen therapy was, however, also a highly significant predictor of relapse during subsequent treatment with AI.
← all excerpts
Assessing the efficacy of targeted therapy using circulating epithelial tumor cells (CETC): the example of SERM therapy monitoring as a unique tool to individualize therapy.
1
—
—